Loading…
View analytic
avatar for Dr Sophie Fletcher

Dr Sophie Fletcher

Respiratory, general and intensive care medicine
BA BM BCh MRCP PG Cert (Med Ed)

Dr Fletcher is the clinical lead for interstitial lung disease (ILD) at University Hospital Southampton. The ILD service in Southampton is a regional service in anticipation of specialist commissioning. It receives both regional and national referrals.

UHS is one of the few centres in the UK able to provide the novel anti-fibrotic drugs pirfenidone and nintedanib. These medicines reduce the body's production of the excess tissue that makes breathing difficult for patients with interstitial lung disease. UHS was the first centre in the UK to provide nintedanib, and one of only 10 centres in England able to offer this option.

Dr Fletcher worked with the British Lung Foundation, the biomedical research unit, the University of Southampton and Portsmouth Hospitals NHS Trust to set up a patient support group for those with ILD – WILD (Wessex ILD). You can find out more about the group by clicking here.

Dr Fletcher is the chair of the Southampton ILD multidisciplinary team meetings and is involved in ongoing research trials in ILD, from translational and clinical research to basic science. She's also a reviewer for the European Respiratory Journal.